Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | GAA | P10253 | 4/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 5/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | CASP6 | P55212 | 2/20 | 0.43 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1606275 | 0.87 | MAPT (0.57) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL157598 | 0.87 | HSD17B10 (0.59) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL8912586 | 0.87 | HSD17B10 (0.60) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL11284193 | 0.86 | HSD17B10 (0.50) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL156095 | 0.86 | HSD17B10 (0.49) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL9251691 | 0.85 | HSD17B10 (0.49) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL11654668 | 0.85 | CTDSP1 (0.52) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL12325555 | 0.85 | KDM4E (0.53) | HSD17B10KDM4EMAPTGAAUSP2 | |
| SCHEMBL11654759 | 0.83 | HSD17B10 (0.57) | HSD17B10KDM4EMAPTGAACTDSP1 | |
| SCHEMBL12325147 | 0.83 | KDM4E (0.51) | HSD17B10KDM4EMAPTGAAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106834267-A | Based on the functional material for fixing methyl parathion degradation bacterium that vermiculite is modified | 光合强化（北京）生物科技有限公司 | 2017-06-13 | — | — | CN | claimed |
| CN-106086499-A | A kind of compound porous metal material and preparation method thereof | 苏州洪河金属制品有限公司 | 2016-11-09 | — | — | CN | claimed |
| EP-0277600-B1 | PROCESS FOR THE PREPARATION OF REACTIVE AZO DYES | BAYER AG (DE) | 1990-03-21 | — | — | EP | claimed |
| EP-0277600-A2 | Process for the preparation of reactive azo dyes | BAYER AG (DE) | 1988-08-10 | — | — | EP | claimed |
| US-20250221408-A1 | COMPOSITION | EARTH CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| CN-119114152-A | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2024-12-13 | — | — | CN | disclosed |
| EP-4473837-A1 | COMPOSITION | Earth Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| CN-118695780-A | Composition and method for producing the same | 阿斯制药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| CN-110769931-B | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2024-09-17 | — | — | CN | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-117281115-A | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2023-12-26 | — | — | CN | disclosed |
| WO-2023190598-A1 | COMPOSITION | アース製薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-0037986-B1 | PROCESS FOR THE PREPARATION OF PHTHALOCYANINE DYESTUFFS | BAYER AG (DE) | 1983-05-11 | — | — | EP | disclosed |
| US-4354968-A | Azo reactive dyestuffs having an aryl-triazinyl-aryl diazo component | BAYER AKTIENGESELLSCHAFT (DE) | 1982-10-19 | — | — | US | disclosed |
| EP-0047427-A1 | 1:2-Chromium complex dyestuffs containing sulfonic-acid groups | BASF Aktiengesellschaft (DE) | 1982-03-17 | — | — | EP | disclosed |
| EP-0037986-A2 | Process for the preparation of phthalocyanine dyestuffs | BAYER AG (DE) | 1981-10-21 | — | — | EP | disclosed |
| US-4283331-A | FIBER-REACTIVE DYES | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4163012-A | DIAZOTIZATION IN THE PRESENCE OF CALCIUM HYDROXIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-31 | — | — | US | disclosed |
| US-4124581-A | FOR NATURAL AND SYNTHETIC FIBERS, COLORFAST | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-07 | — | — | US | disclosed |
| US-3997522-A | POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | HSD17B10 2328/4885KDM4E 4109/4885MAPT 3206/4885 |
| US-20250221408-A1 | COMPOSITION | GGPS1, PGGT1B, HBG2 | HSD17B10 47/4885KDM4E 4450/4885MAPT 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.